Literature DB >> 26314860

Erratum to: Exon 19 deletion of epidermal growth factor receptor is associated with prolonged survival in brain metastases from non-small-cell lung cancer.

Hongwei Li1,2, Xiaqin Zhang3, Jianzhong Cao4, Pengcheng Su3, Jianhong Lian5, Xing Song3, Weihua Yang6, Songyan Han6, Yanfeng Xi7, Yaohua Wang7.   

Abstract

Entities:  

Year:  2015        PMID： 26314860     DOI： 10.1007/s13277-015-3953-6

Source DB:  PubMed          Journal:  Tumour Biol        ISSN： 1010-4283


× No keyword cloud information.
  4 in total

1.  Icotinib combined whole brain radiotherapy for patients with brain metastasis from lung adenocarcinoma harboring epidermal growth factor receptor mutation.

Authors:  Jin-Rui Li; Ye Zhang; Jia-Lian Zheng
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

Review 2.  The optional approach of oncogene-addicted non-small cell lung cancer with brain metastases in the new generation targeted therapies era.

Authors:  Alessia Spagnuolo; Matteo Muto; Fabio Monaco; Giuseppe Colantuoni; Cesare Gridelli
Journal:  Transl Lung Cancer Res       Date:  2019-12

3.  EGFR-TKI plus brain radiotherapy versus EGFR-TKI alone in the management of EGFR-mutated NSCLC patients with brain metastases.

Authors:  Kai Dong; Wenhua Liang; Shen Zhao; Minzhang Guo; Qihua He; Caichen Li; Haiqing Song; Jianxing He; Xiaojun Xia
Journal:  Transl Lung Cancer Res       Date:  2019-06

4.  Risk factors of brain metastasis during the course of EGFR-TKIs therapy for patients with EGFR-mutated advanced lung adenocarcinoma.

Authors:  Xiaoyan Ma; Hui Zhu; Hongbo Guo; Anqin Han; Haiyong Wang; Wang Jing; Yan Zhang; Li Kong; Jinming Yu
Journal:  Oncotarget       Date:  2016-12-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.